A randomized trial of AmBisome monotherapy and combination of AmBisome and miltefosine for the treatment of Visceral Leishmanaisis in HIV positive patients in India.
Phase of Trial: Phase III
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Amphotericin B liposomal (Primary) ; Miltefosine
- Indications Visceral leishmaniasis
- Focus Therapeutic Use
- 06 Feb 2017 Status changed from not yet recruiting to recruiting.
- 01 Sep 2016 New trial record
- 26 Aug 2016 Planned initiation date changed from 19 Sep 2016 to 1 Nov 2016.